National Health (Supply of Pharmaceutical Benefits—Under Co-payment Data and Claims for Payment) Rules 2022
10Procedures for providing information in respect of claims using manual system
Start here
Get a plain-English read of 10
Turn the raw legal text into a practical explanation grounded in National Health (Supply of Pharmaceutical Benefits—Under Co-payment Data and Claims for Payment) Rules 2022.
10 Procedures for providing information in respect of claims using manual system
For the purposes of paragraph 99AAA(8)(d) of the Act, an approved supplier, in providing information otherwise than by electronic means in relation to the supply by the approved supplier of pharmaceutical benefits, must provide the information to the Chief Executive Medicare, on behalf of the Secretary, in accordance with sections 6 and 7 of this instrument.
Note: Paragraphs 9(2)(a), (b), (c) and (d) of this instrument also apply.